1. Home
  2. SFBS vs TVTX Comparison

SFBS vs TVTX Comparison

Compare SFBS & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ServisFirst Bancshares Inc.

SFBS

ServisFirst Bancshares Inc.

HOLD

Current Price

$73.96

Market Cap

3.9B

Sector

Finance

ML Signal

HOLD

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$27.58

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SFBS
TVTX
Founded
2005
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.3B
IPO Year
2014
2013

Fundamental Metrics

Financial Performance
Metric
SFBS
TVTX
Price
$73.96
$27.58
Analyst Decision
Buy
Strong Buy
Analyst Count
3
13
Target Price
$87.50
$36.25
AVG Volume (30 Days)
342.4K
1.0M
Earning Date
04-20-2026
04-30-2026
Dividend Yield
2.04%
N/A
EPS Growth
21.63
92.89
EPS
5.06
N/A
Revenue
N/A
N/A
Revenue This Year
$32.30
$44.62
Revenue Next Year
$10.30
$31.76
P/E Ratio
$14.74
N/A
Revenue Growth
N/A
N/A
52 Week Low
$66.48
$12.91
52 Week High
$90.64
$42.13

Technical Indicators

Market Signals
Indicator
SFBS
TVTX
Relative Strength Index (RSI) 39.92 45.44
Support Level $71.28 $26.72
Resistance Level $76.88 $31.47
Average True Range (ATR) 2.26 1.09
MACD 0.03 0.03
Stochastic Oscillator 51.48 42.49

Price Performance

Historical Comparison
SFBS
TVTX

About SFBS ServisFirst Bancshares Inc.

Servisfirst Bancshares Inc is a bank holding company whose business is conducted by its wholly owned subsidiary. Through the subsidiary, it offers various banking services to individual and corporate customers in Birmingham, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Virginia. Its various products and service offerings include commercial, consumer, and other loans; accepting deposits; providing electronic banking services, such as online and mobile banking, including remote deposit capture; delivering treasury and cash management services; and providing banking services to other financial institutions. The company operates as a single reportable segment, with a majority of its revenue being derived from the business of banking.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Share on Social Networks: